neostigmine has been researched along with Adult Spinal Muscular Atrophy in 2 studies
Neostigmine: A cholinesterase inhibitor used in the treatment of myasthenia gravis and to reverse the effects of muscle relaxants such as gallamine and tubocurarine. Neostigmine, unlike PHYSOSTIGMINE, does not cross the blood-brain barrier.
neostigmine : A quaternary ammonium ion comprising an anilinium ion core having three methyl substituents on the aniline nitrogen, and a 3-[(dimethylcarbamoyl)oxy] substituent at position 3. It is a parasympathomimetic which acts as a reversible acetylcholinesterase inhibitor.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| DESCAMPS, L | 1 |
| Lobzin, VS | 1 |
| Saĭkova, LA | 1 |
| Shiman, AG | 1 |
| Kosachev, VD | 1 |
2 other studies available for neostigmine and Adult Spinal Muscular Atrophy
| Article | Year |
|---|---|
[Myasthenia with amyotrophy, aggravated by prostigmine].
Topics: Humans; Medical Records; Muscular Atrophy, Spinal; Myasthenia Gravis; Neostigmine | 1955 |
[Treatment of patients with Charcot-Marie-Tooth neural amyotrophy].
Topics: Adolescent; Adult; Charcot-Marie-Tooth Disease; Chronic Disease; Drug Evaluation; Drug Therapy, Comb | 1988 |